Login / Signup

Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study.

Joely KaufmanSusan C TaylorSue Ellen CoxSusan H WeinkleStacy SmithBrian M Kinney
Published in: Journal of cosmetic dermatology (2019)
The resilient HA filler made of long chains lightly crosslinked is at least equivalent to a well-established comparator for the correction of NLF in subjects of diverse skin phototypes.
Keyphrases
  • hyaluronic acid
  • double blind
  • placebo controlled
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • wound healing
  • randomized controlled trial
  • cross sectional
  • soft tissue
  • drug induced